Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Muchtar, Eli  [Clear All Filters]
Journal Article
Sidana, S., M Sidiqi, H., Dispenzieri, A., Buadi, F.K., Lacy, M.Q., Muchtar, E., Dingli, D., Hayman, S.R., Gonsalves, W.I., Kapoor, P., et al. (2019). 15 Year Overall Survival Rates after Autologous Stem Cell Transplantation for AL Amyloidosis.Am J Hematol.
M Sidiqi, H., Aljama, M.A., Muchtar, E., Buadi, F.K., Warsame, R., Lacy, M.Q., Dispenzieri, A., Dingli, D., Leung, N., Gonsalves, W.I., et al. (2018). Autologous stem cell transplant for AL amyloidosis patients aged 70 to 75.Biol Blood Marrow Transplant.
Muchtar, E., Lin, G., and Grogan, M. (2020). The Challenges in Chemotherapy and Stem Cell Transplantation for Light-Chain Amyloidosis.Can J Cardiol36, 384-395.
Muchtar, E., Buadi, F.K., Dispenzieri, A., and Gertz, M.A. (2016). Immunoglobulin Light-Chain Amyloidosis: From Basics to New Developments in Diagnosis, Prognosis and Therapy.Acta Haematol135, 172-190.
Muchtar, E., Dispenzieri, A., Kumar, S.K., Dingli, D., Lacy, M.Q., Buadi, F.K., Hayman, S.R., Kapoor, P., Leung, N., Chakraborty, R., et al. (2016). Immunoparesis status in AL amyloidosis at diagnosis affects response and survival by regimen type.Haematologica.
Hwa, Y.L., Gertz, M.A., Kumar, S.K., Lacy, M.Q., Buadi, F.K., Dingli, D., Kapoor, P., Zeldenrust, S.R., Leung, N., Hayman, S.R., et al. (2019). Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis.Leukemia.
M Sidiqi, H., Aljama, M., Jevremovic, D., Muchtar, E., Buadi, F.K., Warsame, R., Lacy, M.Q., Dispenzieri, A., Dingli, D., Gonsalves, W.I., et al. (2018). Prognostic significance of stringent complete response post stem cell transplantation in AL amyloidosis.Biol Blood Marrow Transplant.